Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case-Control Study.

Onco Targets Ther · 2019 · PMC6897378 · PMID 31819535

Europe PMC DOI

hedged sentence

0.0260

closest p · 0.5× alpha

0.0260

boldest claim

The sentences

highly significantp = 0.026actually significant

Fisher’s exact tests showed that the difference between patients with PsPD and TPD was highly significant (p = 0.026 and p = 0.002, respectively).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.